Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 1998
Publications 1998

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aaltonen LA et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
2 Balkau B et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men.
3 Camelon KM et al. The plate model: A visual method of teaching meal planning.
4 Chiasson J-L et al. An international study on the efficacy of an alfa-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data.
5 Collin H-L et al. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus.
6 Dahlöf B et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE Study.
7 DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data.
8 Deeb SS et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.
9 Dietz A et al. Sydämen vajaatoiminta aorttaläpän ahtaumapotilailla.
10 Erkkilä AT et al. Concordance of diet with the recommended cholesterol lowering diet in patients with coronary heart disease.
11 Faergeman O et al. Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S).
12 Fogelholm M et al. Additive effects of the mutations in the beta3-adrenergic receptor and uncoupling protein-1 genes on weight loss and weight maintenance in Finnish women.
13 Haffner SM et al. Proinsulin and insulin concentrations in relation to carotid wall thickness: insulin resistance atherosclerosis study.
14 Haffner SM et al. The authors reply to the editor (to Diabetes and coronary heart disease).
15 Haffner SM et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
16 Haffner SM et al. Leptin concentrations do not predict weight gain: the Mexico City Diabetes Study.
17 Hartikainen J. Sydämen vajaatoiminnan hoito.
18 Hartikainen J. Sydämen tahdistinhoito.
19 Hartikainen JEK et al. Short-term measurement of heart rate variability.
20 Hedman A et al. Physiological background underlying short-term heart rate variability.
21 Heikkinen A-M et al. Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL.
22 Heikkinen A-M et al. Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D.
23 Heikkinen M et al. Answer to Letters to the editor (to Diagnostic methods in dyspepsia: the usefulness of upper abdominal ultrasound and gastroscopy).
24 Heikkinen M et al. Association of CagA-positive and CagA-negative Helicobacter pylori strains with patients' symptoms and gastritis in primary care patients with functional upper abdominal complaints.
25 Heino A et al. Systemic and regional pCO2 gradients as markers of intestinal ischaemia.
26 Hirvonen TPJ et al. Delays in thrombolytic therapy for acute myocardial infarction in Finland: results of a national thrombolytic therapy delay study.
27 Jantunen E, Myllykangas-Luosujärvi R. Kantasolujen siirrot reumataudeissa.
28 Jantunen E, Nousiainen T. Interferonit veritautien hoidossa.
29 Julkunen R. Diagnostiikka ja tutkimusmenetelmät.
30 Julkunen R. Ripuli.
31 Julkunen R. Ärtyvä suoli.
32 Juvonen J et al. Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection?
33 Juvonen PO et al. Lipid peroxidation products and antioxidant capacity in portal venous and systemic arterial plasma during gradual intestinal ischemia and reperfusion in pigs.
34 Jääskeläinen P et al. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.
35 Kansanen M et al. The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome.
36 Karjalainen L et al. Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?
37 Karvonen MK et al. Identification of new sequence variants in the leptin gene.
38 Karvonen MK et al. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels.
39 Kaukoranta PK et al. Myocardial protection during antegrade versus retrograde cardioplegia.
40 Kemppainen TA et al. Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet - association with the grade of mucosal villous atrophy1-3.
41 Ketonen M. Äkillisten sepelvaltimotautikohtausten ilmaantuvuus, hoidon porrastus ja ennuste sekä sepelvaltimotaudin invasiivinen hoito Pohjois-Karjalan ja Pohjois-Savon sairaanhoitopiireissä 1983-1992. Incidence, Arrangement of Care and Prognosis of Acute Coronary Events and Invasive Treatment of Coronary Heart Disease in North Karelia and North Savo Hospital Districts in 1983 - 1992.
42 Koukkunen H et al. Sepelvaltimotaudin sekundaariprevention toteutuminen KYS:ssa hoidetuilla potilailla: EUROASPIRE-tutkimuksen tuloksia.
43 Koukkunen H et al. Troponin T and creatinine kinase isoenzyme MB mass in the diagnosis of myocardial infarction.
44 Kuikka JT et al. Effect of revascularization on (99mTc) sestamibi and (123I)IPPA uptakes in patients with myocardial infarction.
45 Laakso M. Hypertension and macrovascular disease - the killing fields of NIDDM.
46 Laakso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance.
47 Laakso M, Lehto S. Epidemiología de la enfermedad macrovascular en la diabetes.
48 Laitinen M et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia.
49 Laitinen T et al. Age and gender dependency of baroreflex sensitivity in healthy subjects.
50 Lehto S et al. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus.
51 Louheranta AM et al. A high-stearic acid diet does not impair glucose tolerance and insulin sensitivity in healthy women.
52 Lundell L et al. Outcome of open antireflux surgery as assessed in a Nordic Multicentre Prospective Clinical Trial.
53 Majamaa K et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population.
54 Majamaa K et al. Melas-mutaatio monien taudinkuvien takana.
55 Malkki M et al. Functional consequences of naturally occurring variants of human hexokinase II.
56 McLaughlin PR et al. Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angiographic analysis of coronary artery atherosclerosis.
57 Miettinen H et al. Impact of diabetes on mortality after the first myocardial infarction .
58 Mustonen P et al. Significance of coronary artery bypass grafting-associated conduction defects.
59 Nousiainen T et al. Acute neurohumoral and cardiovascular effects of idarubicin in leukemia patients.
60 Pajukanta P et al. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23.
61 Pedersen TR et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S).
62 Pedersen TR et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S).
63 Peuhkurinen K. Reply (to Ischemic preconditioning in children undergoing open heart operation).
64 Pihlajamäki J et al. Different regulation of free fatty acid levels and glucose oxidation by the Trp64Arg polymorphism of the beta3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia.
65 Prepared on behalf of the Task Force by M. C. Petch. Driving and heart disease.
66 Puranen J et al. Risk factors and antiplatelet therapy in TIA and stroke patients.
67 Puranen J et al. Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke.
68 Purokivi M et al. Reumapotilaiden metotreksaattihoidon vakavat haittavaikutukset.
69 Pyörälä K. Sepelvaltimotaudin ehkäisy valokeilassa.
70 Pyörälä K, Wood D. Prevention of coronary heart disease in clinical practice. European recommendations revised and reinforced.
71 Pyörälä M et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.
72 Pyörälä M et al. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: 22-year follw-up results of the Helsinki Policemen Study.
73 Rainio P et al. Ultrastructural changes in myocardium during mild hypothermic retrograde blood cardioplegia.
74 Rissanen J et al. Glucokinase gene islet promoter region variant (G->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns.
75 Ristikankare MKO, Julkunen RJK. Premedication for gastrointestinal endoscopy is a rare practice in Finland: a nationwide survey.
76 Saarinen L et al. Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM.
77 Saltevo J et al. Akuutin alkoholipankreatiitin jälkeiset glukoosiaineenvaihdunnan häiriöt.
78 Simula SH et al. Analogue and digital electrocardiogram recordings in the assessment of heart rate variability.
79 The PARAGON Investigators. International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina.
80 Tikkanen MJ et al. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM: a multicenter comparison study.
81 Valve R et al. Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns.
82 Vanhanen M et al. Cognitive function in an elderly population with persistent impaired glucose tolerance.
83 Vanninen E et al. Sydänlihaksen perfuusion gammakuvauksen uusia mahdollisuuksia: viitearvot ja EKG-tahdistettu yksifotoniemissiotomografia.
84 Vauhkonen I et al. Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus.
85 Vauhkonen I et al. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited: metabolic studies on offspring of diabetic probands.
86 Viinamäki H et al. Factors predictive of referral to psychiatric hospital among general hospital psychiatric consultations.
87 Wood D et al. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on corony prevention.
88 Wood D et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.
89 Wood D et al. Prevention of coronary heart disease in clinical practice: summary of recommendations of the Second Joint Task Force of European and other Societies on coronary prevention.
90 Ågren JJ et al. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene .

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008